Literature DB >> 22602826

Crohn's disease or TB--the perennial question and diagnostic pitfalls.

Rudra Krishna Maitra1, Tim Bowling, Pradhib Venkatesan, Charles Maxwell-Armstrong.   

Abstract

A previously healthy 28-year old lady from Saudi Arabia presented with recurrent peri-anal abscesses progressing to fistula-in-ano. These were treated with incision and drainages and with setonisation of the fistula. Multiple biopsy and culture specimens were taken to rule out tuberculosis (TB) or Crohn's disease - all showed granulomatous disease suggestive of either Crohn's or TB, no mycobacteria were grown. MRI scanning also suggested either TB or Crohn's disease. Tuberculin skin test was inconclusive and Quantiferon Gold test was negative. Treatment for Crohn's was started with oral prednisolone - the patient deteriorated and adalimumab (tumour necrosis factor α antagonist) was commenced. With continued deterioration in the absence of intra-abdominal abscesses, a clinical diagnosis of TB was made, Crohn's treatment suspended and quadruple therapy for TB was initiated. The patient rapidly improved and a delayed re-look histological specimen identified an isolated mycobacterium. Subsequent cultures confirmed drug-sensitive TB. The lady is currently well on TB eradication regimen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22602826      PMCID: PMC3339160          DOI: 10.1136/bcr.01.2012.5620

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  An analysis of some hypotheses related to the Chingelput bacille Calmette-Guérin trial.

Authors:  D Smith; E Wiegeshaus; V Balasubramanian
Journal:  Clin Infect Dis       Date:  2000-09       Impact factor: 9.079

2.  BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.

Authors:  Tina Ding; Jo Ledingham; Raashid Luqmani; Sarah Westlake; Kimme Hyrich; Mark Lunt; Patrick Kiely; Marwan Bukhari; Rikki Abernethy; Ailsa Bosworth; Andrew Ostor; Kate Gadsby; Frank McKenna; Diana Finney; Josh Dixey; Chris Deighton
Journal:  Rheumatology (Oxford)       Date:  2010-09-12       Impact factor: 7.580

3.  Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

Authors:  Gerald H Mazurek; John Jereb; Andrew Vernon; Phillip LoBue; Stefan Goldberg; Kenneth Castro
Journal:  MMWR Recomm Rep       Date:  2010-06-25

4.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

Review 5.  BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment.

Authors: 
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

Review 6.  Abdominal tuberculosis.

Authors:  M P Sharma; Vikram Bhatia
Journal:  Indian J Med Res       Date:  2004-10       Impact factor: 2.375

7.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

8.  Does the efficacy of BCG decline with time since vaccination?

Authors:  J A Sterne; L C Rodrigues; I N Guedes
Journal:  Int J Tuberc Lung Dis       Date:  1998-03       Impact factor: 2.373

9.  Epidemiology and outcome of Crohn's disease in a teaching hospital in Riyadh.

Authors:  Abdullah S Al-Ghamdi; Ibrahim A Al-Mofleh; Rashed S Al-Rashed; Saleh M Al-Amri; Abdulrahman M Aljebreen; Arthur C Isnani; Reda El-Badawi
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

  9 in total
  1 in total

1.  Tuberculosis and TNF-inhibitors: history of exposure should outweigh investigations.

Authors:  Michaela T Reichmann; Ben G Marshall; Fraser Cummings; Paul T Elkington
Journal:  BMJ Case Rep       Date:  2014-05-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.